Home > Protocol Summaries: Compounds > fluticasone propionate Protocol Summaries: fluticasone propionate GSKStudy ID Phase Title Status 114748 phase 2 A randomized, double blind, placebo-controlled three-way crossover study in mild asthmatics to evaluate the effect of smoking status on the attenuation by inhaled corticosteroids of the allergen-induced asthmatic response. Recruiting 116952 WEUSKOP6416: Evaluating serious pneumonia in subjects with Chronic Obstructive Pulmonary Disease (COPD) to inform risk minimization: A Retrospective Observational Study Active not recruiting FAS106533 Phase 1 See Detailed Description Completed FMS40273 phase 4 A study to investigate the effect of inhaled fluticasone propionate on the bronchial responsiveness to leukotriene D4 in asthmatics patients Completed HH3104994 phase 2 A randomised, double blind, placebo controlled, 2-way crossover, 3 phase study, to investigate the trial models, Vienna Challenge Chamber, in and out of season, and Park Study in season and the clinical efficacy of rpt doses of fluticasone propionate in subjects with seasonal allergic rhinitis Completed RH01619 phase 3 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy of Once-Daily Fluticasone Propionate Aqueous Nasal Spray 200mcg for 14 Days on Ocular Symptoms Associated with Seasonal Allergic Rhinitis Completed SCO100648 Phase 3 Clinical Evaluation of GW815SF for Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema) “ A Long-term Treatment Study of GW815SF50/500µg in Chronic Obstructive Pulmonary Disease - Completed SIG103337 Phase 2 See Detailed Description Completed
